NO20065339L - Cholinesteraseinhibitorer i liposomer og deres fremstilling og anvendelse - Google Patents
Cholinesteraseinhibitorer i liposomer og deres fremstilling og anvendelseInfo
- Publication number
- NO20065339L NO20065339L NO20065339A NO20065339A NO20065339L NO 20065339 L NO20065339 L NO 20065339L NO 20065339 A NO20065339 A NO 20065339A NO 20065339 A NO20065339 A NO 20065339A NO 20065339 L NO20065339 L NO 20065339L
- Authority
- NO
- Norway
- Prior art keywords
- liposomes
- topical
- active ingredient
- cutaneous
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
Oppfinnelsen vedrører en farmasøytisk sammensetning basert på en aktiv ingrediens som er innelukket i liposomer for topikal, transdermal påføring. Det indre av nevnte liposomer omfatter et surt, vandig medium som inneholder minst en kolinesterasehemmer, helst fra gruppen som inneholder donepezil, rivastigmin, galantamin, fysostigmin, heptylfysostigmin, fenserin, tolserin, cymserin, tiatolserin, tiacymserin, neostigmin, huperzin, takrin, metrifonat og diklorvos eller en enantiomer eller derivat av minst en av nevnte forbindelser. I tillegg vedrører oppfinnelsen en fremgangsmåte for å produsere nevnte sammensetning, valgfritt i en steril form og også anvendelsen av liposomene som er ladet med den aktive ingrediensen i forskjellige galeniske formuleringer for topikal, transdermal bruk med en depoteffekt i epidermisen, for profylaksen og/eller behandling av kutan neuropatisk smerte eller tapet av kutanøs sensorisk funksjon som et resultat av neuropati.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0069604A AT500143A1 (de) | 2004-04-22 | 2004-04-22 | Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung |
PCT/AT2005/000138 WO2005102268A2 (de) | 2004-04-22 | 2005-04-21 | Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065339L true NO20065339L (no) | 2007-01-09 |
Family
ID=35197479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065339A NO20065339L (no) | 2004-04-22 | 2006-11-21 | Cholinesteraseinhibitorer i liposomer og deres fremstilling og anvendelse |
Country Status (10)
Country | Link |
---|---|
US (1) | US20080031935A1 (no) |
EP (1) | EP1737426A2 (no) |
JP (1) | JP2007533666A (no) |
CN (1) | CN1946377A (no) |
AT (1) | AT500143A1 (no) |
AU (1) | AU2005235430A1 (no) |
CA (1) | CA2563861A1 (no) |
NO (1) | NO20065339L (no) |
RU (1) | RU2006141254A (no) |
WO (1) | WO2005102268A2 (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5731094B2 (ja) * | 2005-02-11 | 2015-06-10 | スティーブン・ウィルスStephen WILLS | アセチルコリンエステラーゼ阻害剤による微小血管系疾患の治療 |
US20060264455A1 (en) | 2005-05-23 | 2006-11-23 | Schachter Steven C | Use of huperzine for disorders |
DE102006056783A1 (de) * | 2006-12-01 | 2008-06-05 | Lts Lohmann Therapie-Systeme Ag | Zubereitung zur transdermalen Verabreichung von Galanthamin |
TWI428135B (zh) * | 2007-03-26 | 2014-03-01 | Hirofumi Takeuchi | And a carrier composition for quick-acting nucleic acid delivery |
CN103370055B (zh) * | 2011-03-25 | 2015-06-24 | 泰尔茂株式会社 | 缓释性脂质体组合物及其制造方法 |
JP5848511B2 (ja) * | 2011-03-29 | 2016-01-27 | 株式会社コーセー | リポソーム組成物、並びにそれを用いた化粧料、皮膚外用剤及びその製造方法 |
CN102178680B (zh) * | 2011-04-24 | 2012-09-05 | 浙江现代中药与天然药物研究院有限公司 | 一种长效高含量的石杉碱甲贴片及其制备方法 |
US9685730B2 (en) | 2014-09-12 | 2017-06-20 | Steelcase Inc. | Floor power distribution system |
GB2561157A (en) * | 2017-03-27 | 2018-10-10 | Univ Oxford Innovation Ltd | Compartmentalised gel matrix and method of production |
KR102046355B1 (ko) * | 2018-02-08 | 2019-11-19 | 국방과학연구소 | 피하주사용 피소스티그민의 서방출성 리포좀 제제 및 이의 제조 방법 |
EP3826615A4 (en) * | 2018-07-24 | 2022-05-04 | Taiwan Liposome Company, Ltd. | DELAYED RELEASE PHARMACEUTICAL COMPOSITIONS WITH A THERAPEUTIC AGENT FOR THE TREATMENT OF DEMENTIA AND USES THEREOF |
TWI767133B (zh) * | 2018-08-02 | 2022-06-11 | 台灣微脂體股份有限公司 | 含有治療憂鬱症或焦慮症之治療劑的緩釋組合物及其用途 |
WO2020033195A1 (en) * | 2018-08-08 | 2020-02-13 | Taiwan Liposome Co., Ltd. | Sustained-release pharmaceutical compositions comprising an antipsychotic drug and uses thereof |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB942200A (en) * | 1959-03-02 | 1963-11-20 | Chimiko Pharmazevtitschen Zd | A method of obtaining galanthamine hydrobromide |
EP0152379A3 (de) * | 1984-02-15 | 1986-10-29 | Ciba-Geigy Ag | Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen |
US4804539A (en) * | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
MX9203808A (es) * | 1987-03-05 | 1992-07-01 | Liposome Co Inc | Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos. |
US4946683A (en) * | 1987-11-18 | 1990-08-07 | Vestar, Inc. | Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes |
US4937078A (en) * | 1988-08-26 | 1990-06-26 | Mezei Associates Limited | Liposomal local anesthetic and analgesic products |
IL91664A (en) * | 1988-09-28 | 1993-05-13 | Yissum Res Dev Co | Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release |
BE1001869A3 (fr) * | 1988-10-12 | 1990-04-03 | Franz Legros | Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine. |
DE3843239C1 (no) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
US5064655A (en) * | 1989-02-24 | 1991-11-12 | Liposome Technology, Inc. | Liposome gel composition and method |
WO1990014105A1 (en) * | 1989-05-15 | 1990-11-29 | The Liposome Company, Inc. | Accumulation of drugs into liposomes by a proton gradient |
IT1254464B (it) * | 1992-02-17 | 1995-09-25 | Enzo Anaclio | Uso di sostanze parasimpaticomimetiche dirette per la terapia del dolore. |
CA2097163C (en) * | 1992-06-01 | 2002-07-30 | Marianna Foldvari | Topical patch for liposomal drug delivery system |
DE4238223C1 (de) * | 1992-11-12 | 1994-05-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung |
DE4301783C1 (de) * | 1993-01-23 | 1994-02-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil |
AT403803B (de) * | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
US5837282A (en) * | 1996-10-30 | 1998-11-17 | University Of British Columbia | Ionophore-mediated liposome loading |
IT1304904B1 (it) * | 1998-09-11 | 2001-04-05 | Eisai Co Ltd | Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche |
EP1406604A2 (en) * | 1999-11-16 | 2004-04-14 | George F. El Khoury | Topical application of muscarinic analgesic drugs such as neostigmine |
MXPA01012275A (es) * | 2000-03-31 | 2003-06-24 | Sanochemia Pharmazeutika Ag | Derivados y analogos novedosos de galantamina. |
WO2001078728A1 (fr) * | 2000-04-13 | 2001-10-25 | Eisai Co., Ltd. | Inhibiteurs d'acetylcholinesterases contenant des sels de 1-benzyl-pyridinium |
EP1300395B1 (en) * | 2000-06-21 | 2009-09-02 | Eisai R&D Management Co., Ltd. | 4-substituted piperidine compound |
EP1203614A1 (de) * | 2000-11-03 | 2002-05-08 | Polymun Scientific Immunbiologische Forschung GmbH | Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln |
DE60223904T2 (de) * | 2001-01-26 | 2008-11-27 | Btg International Ltd. | Benzylaminanalogen |
US6951655B2 (en) * | 2001-10-11 | 2005-10-04 | Imi Biomed, Inc. | Pro-micelle pharmaceutical compositions |
US20030235609A1 (en) * | 2002-01-25 | 2003-12-25 | Lautt Wilfred Wayne | Use of cholinesterase antagonists to treat insulin resistance |
US20030225031A1 (en) * | 2002-05-21 | 2003-12-04 | Quay Steven C. | Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
-
2004
- 2004-04-22 AT AT0069604A patent/AT500143A1/de not_active Application Discontinuation
-
2005
- 2005-04-21 CN CNA2005800125612A patent/CN1946377A/zh active Pending
- 2005-04-21 RU RU2006141254/15A patent/RU2006141254A/ru not_active Application Discontinuation
- 2005-04-21 AU AU2005235430A patent/AU2005235430A1/en not_active Abandoned
- 2005-04-21 WO PCT/AT2005/000138 patent/WO2005102268A2/de active Application Filing
- 2005-04-21 JP JP2007508671A patent/JP2007533666A/ja not_active Withdrawn
- 2005-04-21 CA CA002563861A patent/CA2563861A1/en not_active Abandoned
- 2005-04-21 US US11/578,191 patent/US20080031935A1/en not_active Abandoned
- 2005-04-21 EP EP05731917A patent/EP1737426A2/de not_active Withdrawn
-
2006
- 2006-11-21 NO NO20065339A patent/NO20065339L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1737426A2 (de) | 2007-01-03 |
US20080031935A1 (en) | 2008-02-07 |
WO2005102268A2 (de) | 2005-11-03 |
AU2005235430A1 (en) | 2005-11-03 |
JP2007533666A (ja) | 2007-11-22 |
CN1946377A (zh) | 2007-04-11 |
RU2006141254A (ru) | 2008-05-27 |
AT500143A1 (de) | 2005-11-15 |
CA2563861A1 (en) | 2005-11-03 |
WO2005102268A3 (de) | 2006-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065339L (no) | Cholinesteraseinhibitorer i liposomer og deres fremstilling og anvendelse | |
WO2009011412A3 (en) | Combination of ampa receptor antagonists and acetylcholinesterase inhibitors for the treatment of neuropathic pain | |
NO20080284L (no) | Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer | |
NO950774L (no) | Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol | |
NO20062703L (no) | Maleatsalter av et kinazolinederivater anvenbare som antiangiogenisk middel | |
NO20022442L (no) | Legemidler for sykdommer i forbindelse med reduksjon i benmasse | |
SE0401345D0 (sv) | Therapeutic compounds: Pyridine as scaffold | |
UA92498C2 (ru) | Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм | |
DK1893237T3 (da) | Farmaceutisk sammensætning, der omfatter en organopolysiloxan ela-stomer og et solubiliseret aktivt stof | |
PT1414467E (pt) | Tratamento topico da mastalgia | |
ATE526015T1 (de) | Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien | |
BRPI0414777A (pt) | compostos, composições farmacêuticas, uso de um ou mais compostos, e, método de tratar um paciente que sofre de um distúrbio | |
WO2002043731A3 (en) | Treatments for neurogenetic disorders, impulse control disorders, and wound healing | |
BRPI0407968A (pt) | derivados de oxamida úteis como inibidores de raf-quinase | |
NO20073575L (no) | Farmasoytiske sammensetninger for behandling av cellulitt | |
BRPI0409881A (pt) | compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos | |
BRPI0409878A (pt) | compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos | |
IL190850A (en) | Use of Artemisinin and Derivatives to Prepare a Pharmacist and Insulin Composition Containing Local Compositions Containing Them | |
AR006578A1 (es) | Composiciones fungicidas que comprenden ciprodinil con miclobutanil o iprodiona y que tienen accion sinergica contra las enfermedades de plantas y unmetodo de proteccion contra las enfermedades | |
NO20055254L (no) | Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte | |
NO20064196L (no) | Utvortes preparat for behandling av smertefulle hudskader | |
DE60306503D1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
ATE487492T1 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit | |
UY28251A1 (es) | Uso del hidrocloruro de la base del principio activo 1-(n2-(3,5-dibromo-n-((4-(3,4-dihidro-2 (1h)- oxoquinazolin-3-il)-1-piperidinil)-carbonil)-d-tirosil)-l-lisil)-4-(4-pipperidin)-piperazina en combinación con sumatriptano para el tratamiento de la | |
NO20074768L (no) | Anvendelse av pyrazolderivater for fremstilling av medisiner nyttige for a forebygge eller behandle nyresykdommer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |